Future Research Directions in Asthma. An NHLBI Working Group Report.
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 26305520.
- Also identified by DOI 10.1164/rccm.201505-0963WS and PMC identifier 4731702.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Asthma is a common chronic disease without cure. Our understanding of asthma onset, pathobiology, classification, and management has evolved substantially over the past decade; however, significant asthma-related morbidity and excess healthcare use and costs persist. To address this important clinical condition, the NHLBI convened a group of extramural investigators for an Asthma Research Strategic Planning workshop on September 18-19, 2014, to accelerate discoveries and their translation to patients. The workshop focused on (1) in utero and early-life origins of asthma, (2) the use of phenotypes and endotypes to classify disease, (3) defining disease modification, (4) disease management, and (5) implementation research. This report summarizes the workshop and produces recommendations to guide future research in asthma.
Medical subject headings
- Asthma
- National Heart, Lung, and Blood Institute (U.S.)
- Research